Otrivine Extra Dual Relief Nasal Spray 10ml

Otrivine Extra Dual Relief Nasal Spray is a combination a medicinal product consisting of two different substances (xylometazoline hydrochloride and ipratropium bromide). 

This Nasal spray is used for the treatment of nasal congestion with runny nose (rhinorrhea) in connection with common colds.

Each application delivers a measured dose which works within minutes to clear a blocked nose and helps stop excessive nasal secretions for up to six hours.

• Ipratropium bromide, active ingredient reduces nasal mucus secretion with fast acting effect, usually obtained within 15 minutes and lasting for an average of 6 hours.
• Xylometazoline hydrochloride reduces nasal mucosal swelling giving it a fast acting decongestant effect.

We would suggest that you try not to blow your nose for the first few minutes allowing the medicine to get to work.

• Fast relief from blocked and runny nose due to colds.
• Helps unblock your nose 6x faster than decongestant pills.

For more advice, please visit us on Instagram @rightdose_uk.

This is a medicine. Like all medicines, Otrivine Extra Dual Relief Nasal Spray can cause side effects, although not everybody gets them.
Stop using Otrivine Extra Dual Relief Nasal Spray and seek medical help immediately:

• Severe itching of the skin, with a red rash or raised bumps.
• Signs of an allergic reaction as difficulty breathing, speaking or swallowing.
• If you have palpitations and increased heart rate.
• Swelling of the face, lips, tongue or throat.
• Disturbances of vision (including blurred vision, worsening of glaucoma or increased pressure in the eye), rainbow-coloured circles/haloes around bright lights and/or eye pain.

Other side effects:

• Dry mouth
• Nose bleeding and nasal dryness. Many of the side effects reported are also symptoms of common cold. 
• Nasal discomfort, congestion of the nose, dry and irritated throat, pain in the nose
• Altered taste sensation, headache

In order to minimise the risk of side effects such as nose bleeding and other effects on the nose, it is recommended that you stop treatment with Otrivine Extra Dual Relief Nasal spray when your symptoms improve even if this is sooner than 7 days.

If you get any side effects, talk to your doctor, our Rightdose pharmacists or nurse. This includes any possible side effects not listed in this leaflet.

You can help to make medicines safer by reporting any side-effects to the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.

Before taking any medication, it is important to read the Patient Information Leaflet. You can find information leaflets for your medicines by typing them into the search bar at medicines.org, or by contacting us.

Otrivine Extra Dual Relief Nasal Spray 10ml

Suitable for adults 18 years and above.

Do not use Otrivine Extra Dual Relief Nasal Spray:

• If you suffer from glaucoma (increased pressure in the eye)
• If you had your pituitary gland removed by surgery carried out through the nose
• If you are allergic to Xylometazoline hydrochloride or Ipratropium bromide or any of the other ingredients of this medicine 
• If you are allergic to atropine or similar substances, e.g. hyoscyamine and scopolamine
• If you have had brain surgery where the operation was carried out through the nose or mouth
• If you have a very dry nose (inflammatory nasal dryness, rhinitis sicca).

Always use this medicine exactly as described in this leaflet or your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Directions:
• Always blow your nose before using the nasal spray.
• Remove the dust cap.
• Do not cut the nozzle. The metered-dose spray is ready to prime before use.
• Hold the bottle upright.
• Bend your head slightly forward.
• Close one nostril by placing your finger against the side of your nose and insert the spray tip into the other nostril. Press the pump quickly while inhaling through the nose.
• Repeat this procedure in the other nostril.
The effect occurs within 5-15 minutes

The recommended dose is: One puff in each nostril as needed, up to 3 times daily for maximum of 7 days.

• Leave at least 6 hours between two doses.
• Do not exceed 3 applications daily into each nostril.
• Before the first application, prime the pump by pumping 4 times. Once primed the pump will normally remain charged throughout regular daily treatment periods. Should the spray not be ejected during the full actuation stroke, or if the product has not been used for longer than 6 days, the pump will need to be reprimed with 4 pumps as initially performed. 

It is recommended that you stop treatment with Otrivine Extra Dual Relief Nasal spray as soon as your symptoms improve, even if this is sooner than 7 days, in order to minimise the risk of adverse reactions.

If you think the effect of this medicine is too strong or too weak, consult your doctor or pharmacist.

Do not use Otrivine Extra Dual Relief Nasal Spray:
• In children below 18 years of age, as adequate information on safety and efficacy is not available
• If you are allergic to Xylometazoline hydrochloride or ipratropium bromide or any of the other ingredients of this
medicine
• If you are allergic to atropine or similar substances, e.g. hyoscyamine and scopolamine
• If you had your pituitary gland removed by surgery carried out through the nose
• If you have had brain surgery where the operation was carried out through the nose or mouth
• If you suffer from glaucoma (increased pressure in the eye)
• If you have a very dry nose (inflammatory nasal dryness, rhinitis sicca).
Warnings and precautions:
Talk to your doctor or pharmacist before using Otrivine Extra Dual Relief Nasal Spray if you have underlying condition e.g.: heart disease, raised blood pressure, diabetes, an overactive thyroid gland etc.

Immediate hypersensitivity (allergic reaction) may occur in rare cases. This may be seen as itchy red rash with raised inflammation of the skin (hives), difficulty breathing or speaking, difficulty swallowing due to swelling of the lips, face or throat. 

Otrivine Extra Dual Relief Nasal Spray is not recommended for use in children and adolescents below 18 years or in the elderly above 70 years of age.

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor
or pharmacist for advice before taking this medicine.
Visual disturbances (including blurred vision and dilation of the pupil), dizziness and fatigue have been reported with Otrivine Extra Dual Relief Nasal Spray. If affected, you should avoid driving, operating machinery.

Active ingredients: 

Xylometazoline hydrochloride and ipratropium bromide.

• 1 ml contains 0.5 mg xylometazoline hydrochloride and 0.6 mg ipratropium bromide.
• 1 puff contains 70 micrograms xylometazoline hydrochloride and 84 micrograms ipratropium bromide.

Contains:

Disodium edetate, glycerol (85%), purified water, sodium hydroxide and hydrochloric acid.

The bottle contains approximately 70 puffs.